NEW YORK (360Dx) – Mologic and Fraunhofer today announced a collaboration to develop a rapid, point-of-care test for the diagnosis of bacterial urinary tract infections and any associated antibiotic susceptibility.

The test being developed would be used in a primary care setting. Fraunhofer was awarded £900,000 ($1.3 million) by SBRI Healthcare, a National Health Service England Initiative, in support of the project, the companies said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.